Wells Fargo upgrades CareDx after a 30% pullback in stock
Wells Fargo upgraded Caredx Inc (NASDAQ:CDNA) to "Equal Weight" from "Underweight" given a more balanced risk/reward profile after a roughly 30% decline in the stock since late August, contrasting ...
Wells Fargo upgrades CareDx, but lowers price target
Wells Fargo has upgraded CareDx (NASDAQ:CDNA) to equal weight from underweight, citing valuation, but lowered its price ...
CareDx: Balancing Growth Prospects and Risks with a Hold Rating
In a report released today, Yi Chen from H.C. Wainwright reiterated a Hold rating on CareDx (CDNA – Research Report), with a price target of ...
CareDx Expects Q4 30% Increase In Q4 Preliminary Revenue, Shares Up In Premarket
(RTTNews) - CareDx, Inc. (CDNA), Monday reported preliminary loss for the fourth quarter and a 30 percent increase preliminary revenues. For the quarter, the company projects loss to be approximately ...
CareDx guides Q4 revenue above estimates
CareDx (NASDAQ:CDNA) expects to incur a loss (GAAP) of around $32M to $34M for the fourth quarter of 2024, on revenue of $85M ...
CareDx Announces Preliminary Fourth Quarter and Full Year 2024 Results
The Transplant Company™ – today reported preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2024.